Defibrio AS
PrivateLast Round
VC Round
Jun 18, 2025
Total Funding Raised
$12.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Defibrio AS operates in Healthcare & Life Sciences and is based in Arlington, Massachusetts. Its latest recorded funding round was a VC Round in June 2025.
Defibrio AS is a healthtech company that develops smartphone-powered automated external defibrillators (AEDs) designed to provide accessible and cost-effective emergency cardiac care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Defibrio AS Comparables
Compare Defibrio AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HeartHero, Inc. | 84% | |
| Rapid Response Revival Research Limited | 82% | |
| Avive | 74% |
For institutional investors. Book with your work email.
Defibrio AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2025 | ||||
| Seed | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Defibrio AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rieber & Søn | VC Round |
| Kistefos | VC Round |
| ProVenture | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 32% MoM.
- Jun 25, 2026
Monthly visitors grew 292% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
Defibrio AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Defibrio AS's valuation, stock price, and market status.
Is Defibrio AS a public or private company?
Defibrio AS is a private company.
What is the current stock price of Defibrio AS?
Defibrio AS is a private company, so its shares have no public market price. Caplight tracks Defibrio AS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Defibrio AS worth (valuation)?
Valuation information for Defibrio AS is not publicly available.
Can I buy Defibrio AS stock?
Defibrio AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Defibrio AS's last funding round?
Defibrio AS's most recent funding round was VC Round on June 18, 2025.
Who are the main investors in Defibrio AS?
Key investors in Defibrio AS include Kistefos.
Will Defibrio AS IPO soon?
No public IPO plans have been announced for Defibrio AS.
How can I track Defibrio AS secondary market activity?
Caplight tracks bids, offers, and trades in Defibrio AS's shares on secondary markets.